why choose us

First received: July 27, 2022

Clinical Trial: MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gestational Diabetes Mellitus

Study Type: INTERVENTIONAL


Official Title: MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome: a Multicentre Double-blind Randomised Controlled Trial

Brief Summary: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age.PCOS is a heterogeneous condition, characterised by metabolic disturbances, insulin resistance and hyperandrogenism.Pregnancies in women with PCOS have an increased risk of gestational diabetes mellitus, preeclampsia and preterm birth, and their offspring have an increased risk of aberrant birth weight and hospitalization.After pregnancy, PCOS is thought to have an impact on breastfeeding success and breastmilk…

Read more